Northside Capital Management’s Eli Lilly LLY Stock Holding History

Northside Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25.1M	Buy	20,894 +618	+3%	+$631K	2.05%	12
2026 Q1	$18.6M	Hold	20,276	–	–	1.64%	16
2025 Q4	$21.8M	Buy	20,276 +13	+0.1%	+$12.4K	1.89%	14
2025 Q3	$15.5M	Buy	20,263 +210	+1%	+$156K	1.41%	21
2025 Q2	$15.6M	Buy	20,053 +2,400	+14%	+$1.86M	1.19%	21
2025 Q1	$14.6M	Buy	17,653 +28	+0.2%	+$23.3K	2.37%	7
2024 Q4	$13.6M	Hold	17,625	–	–	3.62%	8
2024 Q3	$15.6M	Hold	17,625	–	–	2.44%	7
2024 Q2	$16M	Hold	17,625	–	–	2.74%	6
2024 Q1	$13.7M	Hold	17,625	–	–	2.45%	8
2023 Q4	$10.3M	Hold	17,625	–	–	3.22%	8
2023 Q3	$9.47M	Hold	17,625	–	–	2.18%	10
2023 Q2	$8.27M	Hold	17,625	–	–	2.86%	9
2023 Q1	$6.05M	Hold	17,625	–	–	1.63%	11
2022 Q4	$6.45M	Buy	17,625 +159	+0.9%	+$56.4K	1.94%	11
2022 Q3	$5.65M	Hold	17,466	–	–	1.83%	12
2022 Q2	$5.66M	Hold	17,466	–	–	1.79%	13
2022 Q1	$5M	Hold	17,466	–	–	1.33%	12
2021 Q4	$4.82M	Hold	17,466	–	–	1.28%	12
2021 Q3	$4.04M	Hold	17,466	–	–	1.11%	12
2021 Q2	$4.01M	Hold	17,466	–	–	1.01%	12
2021 Q1	$3.26M	Buy	17,466 +52	+0.3%	+$10.2K	0.9%	14
2020 Q4	$2.94M	Hold	17,414	–	–	0.87%	15
2020 Q3	$2.58M	Hold	17,414	–	–	0.84%	17
2020 Q2	$2.86M	Hold	17,414	–	–	0.99%	15
2020 Q1	$2.42M	Sell	17,414 -466	-3%	-$64K	1.18%	14
2019 Q4	$2.35M	Hold	17,880	–	–	0.8%	16
2019 Q3	$2M	Buy	17,880 +477	+3%	+$53.1K	0.71%	18
2019 Q2	$1.93M	Hold	17,403	–	–	0.76%	14
2019 Q1	$2.26M	Hold	17,403	–	–	0.9%	12
2018 Q4	$2.01M	Buy	17,403 +129	+0.7%	+$14.4K	0.89%	12
2018 Q3	$1.85M	Hold	17,274	–	–	0.66%	17
2018 Q2	$1.47M	Hold	17,274	–	–	0.52%	20
2018 Q1	$1.34M	Hold	17,274	–	–	0.44%	23
2017 Q4	$1.46M	Hold	17,274	–	–	0.42%	22
2017 Q3	$1.48M	Hold	17,274	–	–	0.62%	18
2017 Q2	$1.42M	Hold	17,274	–	–	0.62%	18
2017 Q1	$1.45M	Hold	17,274	–	–	0.4%	27
2016 Q4	$1.27M	Hold	17,274	–	–	0.45%	19
2016 Q3	$1.39M	Hold	17,274	–	–	0.54%	18
2016 Q2	$1.36M	Hold	17,274	–	–	0.65%	17
2016 Q1	$1.24M	Sell	17,274 -56	-0.3%	-$4.24K	0.78%	19
2015 Q4	$1.46M	Hold	17,330	–	–	1.12%	12
2015 Q3	$1.45M	Hold	17,330	–	–	1.1%	14
2015 Q2	$1.45M	Hold	17,330	–	–	0.97%	14
2015 Q1	$1.26M	Hold	17,330	–	–	0.86%	15
2014 Q4	$1.2M	Buy	+17,330	New	+$1.17M	0.86%	14

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Northside Capital Management's LLY Position: Q2 2026 in Review

Northside Capital Management increased its Eli Lilly (LLY) stake by 3% in Q2 2026, buying an estimated $631K and bringing the position to 20,894 shares worth $25.1M. The position accounts for 2.05% of the portfolio, ranked #12.

Northside Capital Management first reported a position in LLY in Q4 2014 and has held it in 47 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Northside Capital Management held 20,894 shares of Eli Lilly worth $25.1M as of Q2 2026.
Northside Capital Management bought 618 Eli Lilly shares in Q2 2026, an estimated $631K.
Eli Lilly made up 2.05% of Northside Capital Management's portfolio in Q2 2026, its #12 holding.
Northside Capital Management first reported a position in Eli Lilly in Q4 2014 and has held it in 47 quarters since.
1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Northside Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.